You are here

  • Home
  • Archive
  • Volume 75, Issue 9
  • Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy

Article metrics

Article menu
Download PDFPDF
Original research
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy

 

Online download statistics by month:

Online download statistics by month: May 2021 to September 2024

AbstractFullPdf
May 202110218136
Jun 2021392612
Jul 202133208
Aug 2021211511
Sep 202159449
Oct 20212301811
Nov 202126174
Dec 202119294
Jan 2022247139
Feb 2022225117
Mar 20222952311
Apr 202215687
May 20222241411
Jun 202217473
Jul 2022176175
Aug 20226314623
Sep 20226334436
Oct 20222961816
Nov 2022280258
Dec 2022212136
Jan 202318595
Feb 2023192156
Mar 202328293
Apr 2023121266
May 20239085
Jun 20232341410
Jul 20238283
Aug 20238943
Sep 20238732
Oct 20239962
Nov 2023128139
Dec 202313578
Jan 20249743
Feb 20248465
Mar 202417196
Apr 2024132119
May 202412452
Jun 202412353
Jul 20249589
Aug 20246855
Sep 202415844
Total8181638345